Company Analysis

Halozyme Therapeutics, Inc. (HALO)

Nasdaq: HALO · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2001
Grade6.8
◀ Past 7.9● Present 7.3▶ Future 5.2

Filings

273 filings since 2017 beside 469 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Mar 23, 2026.

Filings a yearinsider forms included
62727159901028386
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Sep 30, 2026.
Insider forms 469

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2026 8-K item 5.02 Officer or director change · Current report Sep 28, 2026
Sep 22, 2026 8-K items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Sep 18, 2026 8-K items 8.01, 9.01 Other event · Current report Sep 17, 2026
Sep 16, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 18, 2026 8-K item 5.02 Officer or director change · Current report Aug 14, 2026
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 2, 2026 8-K item 5.02 Officer or director change · Current report Jun 30, 2026
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
May 7, 2026 8-K item 5.07 Shareholder vote · Current report May 5, 2026
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Apr 24, 2026 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report Apr 22, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 23, 2026 ARS Annual report to shareholders Dec 31, 2025
Mar 23, 2026 DEFA14A Extra proxy material
Mar 23, 2026 DEF 14A Proxy statement Dec 31, 2025
Mar 12, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Feb 17, 2026 10-K Annual report Dec 31, 2025
Feb 17, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 28, 2026 8-K items 2.02, 9.01 Results released · Current report
Dec 9, 2025 8-K item 5.02 Officer or director change · Current report Dec 4, 2025
Dec 8, 2025 8-K item 5.02 Officer or director change · Current report Dec 4, 2025
Nov 24, 2025 8-K item 5.02 Officer or director change · Current report Nov 18, 2025
Nov 18, 2025 S-8 Employee stock plan registration
Nov 12, 2025 8-K items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report Nov 6, 2025
Nov 7, 2025 8-K items 8.01, 9.01 Other event · Current report Nov 6, 2025
Nov 5, 2025 8-K items 1.01, 2.03, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Other event · Current report
Nov 3, 2025 10-Q Quarterly report Sep 30, 2025
Nov 3, 2025 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
Oct 14, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 6, 2025 8-K item 5.02 Officer or director change · Current report Oct 1, 2025
Oct 3, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report Sep 30, 2025
Oct 1, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Sep 30, 2025
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 17, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 273 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton HALO · research, not advice